We are live on
!
Find out more
CBIO
Crescent Biopharma
CBIO
CBIO
41 hedge funds and large institutions have $7.56M invested in Crescent Biopharma in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
152% more capital invested
Capital invested by funds: $3M → $7.56M (+$4.55M)
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
45% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 11
14% more funds holding
Funds holding: 36 → 41 (+5)
0.19% more ownership
Funds ownership: 0.28% → 0.47% (+0.19%)
Holders
41
Holders Change
+5
Holders Change %
+13.89%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
6
Reduced
4
Closed
11
Calls
$26K
Puts
–
Net Calls
+$26K
Net Calls Change
+$26K
Top Buyers
Top Sellers
| 1 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$332K |
| 2 |
Renaissance Technologies
New York
|
-$202K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$97.1K |
| 4 |
Two Sigma Advisers
New York
|
-$42.1K |
| 5 |
HWA
HCR Wealth Advisors
Los Angeles,
California
|
-$16.9K |
